XENE Jan 2025 42.500 call
| Previous close | 8.99 |
| Open | N/A |
| Bid | 4.10 |
| Ask | 5.90 |
| Strike | 42.50 |
| Expiry date | 2025-01-17 |
| Day's range | 8.99 - 8.99 |
| Contract range | N/A |
| Volume | |
| Open interest | 93 |
Insider MonkeyIs Xenon Pharmaceuticals Inc. (XENE) One of the Best Healthcare Stocks Under $50?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Xenon Pharmaceuticals Inc. (NASDAQ:XENE) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]
GlobeNewswireXenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
VANCOUVER, British Columbia, June 05, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the Goldman Sachs 45th Annual Global Healthcare Conference taking place June 10-13, 2024 in Miami, FL. Fireside Chat Presentation Details: Date:Wednesday, June 12, 2024Time:4:00 pm Eastern TimeWebcast:Register herePresenters:Ian Mortimer, President and Chief Executive OfficerChris Von Seggern, C
Simply Wall St.Shareholders Will Probably Not Have Any Issues With Xenon Pharmaceuticals Inc.'s (NASDAQ:XENE) CEO Compensation
Key Insights Xenon Pharmaceuticals to hold its Annual General Meeting on 4th of June Total pay for CEO Ian Mortimer...
